• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管化心脏球体作为研究心脏纤维化的新型三维体外模型

Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.

作者信息

Figtree Gemma A, Bubb Kristen J, Tang Owen, Kizana Eddy, Gentile Carmine

机构信息

Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

出版信息

Cells Tissues Organs. 2017;204(3-4):191-198. doi: 10.1159/000477436. Epub 2017 Aug 4.

DOI:10.1159/000477436
PMID:28772272
Abstract

Spheroid cultures are among the most explored cellular biomaterials used in cardiovascular research, due to their improved integration of biochemical and physiological features of the heart in a defined architectural three-dimensional microenvironment when compared to monolayer cultures. To further explore the potential use of spheroid cultures for research, we engineered a novel in vitro model of the heart with vascularized cardiac spheroids (VCSs), by coculturing cardiac myocytes, endothelial cells, and fibroblasts isolated from dissociated rat neonatal hearts (aged 1-3 days) in hanging drop cultures. To evaluate the validity of VCSs in recapitulating pathophysiological processes typical of the in vivo heart, such as cardiac fibrosis, we then treated VCSs with transforming growth factor beta 1 (TGFβ1), a known profibrotic agent. Our mRNA analysis demonstrated that TGFβ1-treated VCSs present elevated levels of expression of connective tissue growth factor, fibronectin, and TGFβ1 when compared to control cultures. We demonstrated a dramatic increase in collagen deposition following TGFβ1 treatment in VCSs in the PicroSirius Red-stained sections. Doxorubicin, a renowned cardiotoxic and profibrotic agent, triggered apoptosis and disrupted vascular networks in VCSs. Taken together, our findings demonstrate that VCSs are a valid model for the study of the mechanisms involved in cardiac fibrosis, with the potential to be used to investigate novel mechanisms and therapeutics for treating and preventing cardiac fibrosis in vitro.

摘要

与单层培养相比,球体培养能够在特定的三维微环境中更好地整合心脏的生化和生理特征,因此是心血管研究中探索最多的细胞生物材料之一。为了进一步探索球体培养在研究中的潜在用途,我们构建了一种新型的心脏体外模型——血管化心脏球体(VCSs),方法是将从新生大鼠心脏(1 - 3日龄)分离的心肌细胞、内皮细胞和成纤维细胞在悬滴培养中共同培养。为了评估VCSs在重现体内心脏典型病理生理过程(如心脏纤维化)方面的有效性,我们随后用已知的促纤维化剂转化生长因子β1(TGFβ1)处理VCSs。我们的mRNA分析表明,与对照培养相比,经TGFβ1处理的VCSs中结缔组织生长因子、纤连蛋白和TGFβ1的表达水平升高。在天狼星红染色切片中,我们证明TGFβ1处理后VCSs中的胶原蛋白沉积显著增加。阿霉素是一种著名的心脏毒性和促纤维化剂,可引发VCSs中的细胞凋亡并破坏血管网络。综上所述,我们的研究结果表明,VCSs是研究心脏纤维化相关机制的有效模型,具有在体外研究治疗和预防心脏纤维化新机制及疗法的潜力。

相似文献

1
Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.血管化心脏球体作为研究心脏纤维化的新型三维体外模型
Cells Tissues Organs. 2017;204(3-4):191-198. doi: 10.1159/000477436. Epub 2017 Aug 4.
2
Stem Cell-Derived Cardiac Spheroids as 3D In Vitro Models of the Human Heart Microenvironment.干细胞衍生的心脏球体作为人类心脏微环境的3D体外模型
Methods Mol Biol. 2019;2002:51-59. doi: 10.1007/7651_2018_187.
3
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology.心脏球体作为体外生物工程心脏组织用于研究人类心脏病理生理学。
J Vis Exp. 2021 Jan 23(167). doi: 10.3791/61962.
4
Ryanodine Receptor Type 2 Plays a Role in the Development of Cardiac Fibrosis under Mechanical Stretch Through TGFβ-1.2型兰尼碱受体在机械拉伸诱导的心脏纤维化发展过程中通过转化生长因子β-1发挥作用。
Int Heart J. 2017 Dec 12;58(6):957-961. doi: 10.1536/ihj.16-572. Epub 2017 Nov 22.
5
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids.通过 3D 细胞球体的体外心脏组织模型研究心脏纤维化流变学。
J Mech Behav Biomed Mater. 2024 Jul;155:106571. doi: 10.1016/j.jmbbm.2024.106571. Epub 2024 May 10.
6
Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.诱导多能干细胞来源的人心肌细胞无支架三维球体模型的构建与表征
Tissue Eng Part C Methods. 2015 Aug;21(8):852-61. doi: 10.1089/ten.TEC.2014.0376. Epub 2015 Mar 16.
7
Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ₁/SMAD Signaling.缺氧微血管内皮细胞中的内皮间质转化及旁分泌诱导的心肌细胞凋亡是通过 TGFβ₁/SMAD 信号通路介导的。
Int J Mol Sci. 2017 Oct 31;18(11):2290. doi: 10.3390/ijms18112290.
8
Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.I型纤溶酶原激活物抑制剂调控心肌细胞转化生长因子-β及心脏纤维化。
Circulation. 2017 Aug 15;136(7):664-679. doi: 10.1161/CIRCULATIONAHA.117.028145. Epub 2017 Jun 6.
9
1,25 Dihydroxyvitamin D3 Inhibits TGFβ1-Mediated Primary Human Cardiac Myofibroblast Activation.1,25-二羟基维生素D3抑制转化生长因子β1介导的原代人心脏成肌纤维细胞活化。
PLoS One. 2015 Jun 10;10(6):e0128655. doi: 10.1371/journal.pone.0128655. eCollection 2015.
10
Wnt10b Gain-of-Function Improves Cardiac Repair by Arteriole Formation and Attenuation of Fibrosis.Wnt10b功能获得通过小动脉形成和纤维化减轻改善心脏修复。
Circ Res. 2015 Oct 9;117(9):804-16. doi: 10.1161/CIRCRESAHA.115.306886. Epub 2015 Sep 3.

引用本文的文献

1
Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVNS in Managing Heart Failure in Type 2 Diabetes Mellitus.心率变异性、微血管功能障碍与炎症:探索经皮耳迷走神经刺激疗法(taVNS)在2型糖尿病性心力衰竭管理中的潜力
Biomolecules. 2025 Mar 29;15(4):499. doi: 10.3390/biom15040499.
2
Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models.身披胶原蛋白:二维和三维心脏纤维化模型
Int J Mol Sci. 2025 Mar 26;26(7):3038. doi: 10.3390/ijms26073038.
3
Numerical modeling of oxygen diffusion in tissue spheroids undergoing fusion using function representation and finite volumes.
使用函数表示法和有限体积法对正在融合的组织球状体中的氧气扩散进行数值模拟。
Sci Rep. 2025 Feb 11;15(1):5054. doi: 10.1038/s41598-025-86805-2.
4
Lesson on obesity and anatomy of adipose tissue: new models of study in the era of clinical and translational research.肥胖与脂肪组织解剖学课程:临床与转化研究时代的新研究模型。
J Transl Med. 2024 Aug 14;22(1):764. doi: 10.1186/s12967-024-05547-3.
5
Current trends and research topics regarding organoids: A bibliometric analysis of global research from 2000 to 2023.类器官的当前趋势和研究主题:2000年至2023年全球研究的文献计量分析
Heliyon. 2024 Jun 15;10(12):e32965. doi: 10.1016/j.heliyon.2024.e32965. eCollection 2024 Jun 30.
6
TGFβ1 Regulates Cellular Composition of In Vitro Cardiac Perivascular Niche Based on Cardiospheres.TGFβ1 根据心脏球状体调节体外心脏血管周龛细胞组成。
Bull Exp Biol Med. 2024 May;177(1):115-123. doi: 10.1007/s10517-024-06142-8. Epub 2024 Jul 4.
7
Organs in orbit: how tissue chip technology benefits from microgravity, a perspective.轨道中的器官:组织芯片技术如何从微重力中获益,一种观点。
Front Lab Chip Technol. 2024;3. doi: 10.3389/frlct.2024.1356688. Epub 2024 Mar 7.
8
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids.通过 3D 细胞球体的体外心脏组织模型研究心脏纤维化流变学。
J Mech Behav Biomed Mater. 2024 Jul;155:106571. doi: 10.1016/j.jmbbm.2024.106571. Epub 2024 May 10.
9
Vascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics.用于测试治疗药物毒性的血管化心脏类器官芯片。
Sci Rep. 2024 Feb 9;14(1):3370. doi: 10.1038/s41598-024-53678-w.
10
Bridging the Translational Gap in Heart Failure Research: Using Human iPSC-derived Cardiomyocytes to Accelerate Therapeutic Insights.弥合心力衰竭研究中的转化差距:利用人诱导多能干细胞衍生的心肌细胞加速治疗见解。
Methodist Debakey Cardiovasc J. 2023 Nov 16;19(5):5-15. doi: 10.14797/mdcvj.1295. eCollection 2023.